MeiraGTx Holdings plc MGTX
- AAV-hAQP1 — Radiation-Induced Xerostomia Phase 2
- AAV-hAQP1 — Sjogren's Syndrome Preclinical
AQP1 (1 companies · 2 programs)
Companies with an active program directed at AQP1.
Companies with an active program directed at AQP1.